These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
652 related articles for article (PubMed ID: 34360616)
1. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives. Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome-a meta-analysis of preclinical trials. Wang F; Fang B; Qiang X; Shao J; Zhou L Respir Res; 2020 Nov; 21(1):307. PubMed ID: 33218340 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease. Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782 [No Abstract] [Full Text] [Related]
5. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Qin H; Zhao A Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302 [TBL] [Abstract][Full Text] [Related]
6. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250 [TBL] [Abstract][Full Text] [Related]
7. Recent progress in mesenchymal stem cell-based therapy for acute lung injury. Liang J; Dai W; Xue S; Wu F; Cui E; Pan R Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563 [TBL] [Abstract][Full Text] [Related]
8. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome. Han J; Liu Y; Liu H; Li Y Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004 [TBL] [Abstract][Full Text] [Related]
9. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911 [TBL] [Abstract][Full Text] [Related]
10. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Al-Khawaga S; Abdelalim EM Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757 [TBL] [Abstract][Full Text] [Related]
11. Inhaled Placental Mesenchymal Stromal Cell Secretome from Two- and Three-Dimensional Cell Cultures Promotes Survival and Regeneration in Acute Lung Injury Model in Mice. Kudinov VA; Artyushev RI; Zurina IM; Zorina ES; Lapshin RD; Snopova LB; Mukhina IV; Saburina IN Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408778 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia. Hezam K; Mo R; Wang C; Liu Y; Li Z Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities. Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694 [TBL] [Abstract][Full Text] [Related]
14. A Bibliometric Analysis of Mesenchymal Stem Cell-Derived Exosomes in Acute Lung Injury/Acute Respiratory Distress Syndrome from 2013 to 2022. Zhou W; Hu S; Wu Y; Xu H; Zhu L; Deng H; Wang S; Chen Y; Zhou H; Lv X; Li Q; Yang H Drug Des Devel Ther; 2023; 17():2165-2181. PubMed ID: 37521034 [TBL] [Abstract][Full Text] [Related]
15. Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives. Mattoli S; Schmidt M Adv Ther; 2023 Jun; 40(6):2626-2692. PubMed ID: 37069355 [TBL] [Abstract][Full Text] [Related]
16. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828 [TBL] [Abstract][Full Text] [Related]
17. Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome. Li J; Huang S; Wu Y; Gu C; Gao D; Feng C; Wu X; Fu X Int Wound J; 2014 Apr; 11(2):114-21. PubMed ID: 24373614 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome. Wang YY; Li XZ; Wang LB Stem Cell Res Ther; 2013 May; 4(3):45. PubMed ID: 23673003 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease. Worthington EN; Hagood JS Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]